Scientific article compiling the most recent drug development projects currently in the preclinical and clinical phases.

Marta Pascual-Gilabert a, Arturo López-Castel b,c,d, Ruben Artero b,c,d (2021). Myotonic dystrophy type 1 drug development: A pipeline toward the market. Drug Discovery Today, 26(7), 1765–1772.
- https://doi.org/10.1016/j.drudis.2021.03.024
- https://www.sciencedirect.com/science/article/pii/S1359644621001604

MyoDM, a breakthrough in the treatment of Steinert's Myotonic Dystrophy. Research and innovation at the service of your well-being.

¿Do you have any questions
or need more information?

Fill out the form and our team will respond as soon as possible.

Related news.

Scientific article with a complete overview through 2022 of the most recent drug development programs undergoing preclinical and clinical evaluation.

View report

Doctoral thesis

Highest qualification awarded by the Thesis Committee: Dr. Rafael Mañez Mendiluce**, Dr. Carmen Escolano Mirón***, Arturo López Castel****

Myogem’s MyoDM clinical study successfully completes patient recruitment. Post on LinkedIn

At the end of February 2021, the patient recruitment phase of the clinical study NCT04634682 by Myogem concluded. The study...